Supreme Court Mulls Review Of Case On Antitrust Law In Drug Patent Settlements

Law360, New York (June 4, 2004, 12:00 AM EDT) -- In a closely watched controversy over patent settlements and antitrust law, drug makers Abbott Laboratories and Sandoz have urged the Supreme Court not to review a ruling that upholds the right of drug originators to pay generic firms to stay off the market.

The Supreme Court has scheduled a June 17 conference to determine if it should review the ruling.

Abbott and Geneva maintain that it would be premature for the Court to address this issue as several appeals courts are currently considering similar cases, according...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.